Mostrar 1 - 3 resultats de 3 per cerca 'R. Taylor Sundby (15049851)', hora de la petició: 0.01sec Refinar resultats
  1. 1
    Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

    Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma per Srivandana Akshintala (16610490)

    Publicat 2025
    Altres autors: “…R. Taylor Sundby (15049851)…”
    Afegir a favorits
    Guardat en:
  2. 2
    Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

    Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma per Srivandana Akshintala (16610490)

    Publicat 2025
    Altres autors: “…R. Taylor Sundby (15049851)…”
    Afegir a favorits
    Guardat en:
  3. 3
    Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

    Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carci... per John A. Ligon (15024477)

    Publicat 2025
    Altres autors: “…R. Taylor Sundby (15049851)…”
    Afegir a favorits
    Guardat en:

Eines de cerca: